{"entity":{"type":"insider","cik":"0001302448","url":"/insider/0001302448","json_url":"/insider/0001302448.json","name":"Shafer Bradford J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":85,"n_filings":17,"first":"2004-10-07","last":"2018-08-29","span_basis":"filed_date"},"name_variants":[{"name":"Shafer Bradford J","source":"filing","n_filings":17,"first_seen":"2004-10-07","last_seen":"2018-08-29"}],"transactions":[{"id":6231003,"accession":"0001179110-18-011003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-011003","line_url":"/filing/0001179110-18-011003#line-1","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7119.0,"shares_display":"7,119","price_per_share":27.712,"price_display":"27.71","price_state":"stated","total_value":197281.728,"total_display":"197,281.73","total_whole":"197,282","shares_owned_after":84000.0,"shares_owned_after_display":"84,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-27","filed_date":"2018-08-29","scope":"insider"},{"id":5955468,"accession":"0001179110-18-010467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-18-010467","line_url":"/filing/0001179110-18-010467#line-3","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25355.0,"shares_display":"25,355","price_per_share":27.8518,"price_display":"27.85","price_state":"stated","total_value":706182.389,"total_display":"706,182.39","total_whole":"706,182","shares_owned_after":98124.0,"shares_owned_after_display":"98,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-09","scope":"insider"},{"id":5955465,"accession":"0001179110-18-010467","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-010467","line_url":"/filing/0001179110-18-010467","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5945.0,"shares_display":"5,945","price_per_share":28.325101648444072,"price_display":"28.33","price_state":"stated","total_value":168392.7293,"total_display":"168,392.73","total_whole":"168,393","shares_owned_after":123479.0,"shares_owned_after_display":"123,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-07","filed_date":"2018-08-09","scope":"insider","n_lines":2},{"id":5955297,"accession":"0001179110-18-008316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-008316","line_url":"/filing/0001179110-18-008316#line-2","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":23.6564,"price_display":"23.66","price_state":"stated","total_value":92259.96,"total_display":"92,259.96","total_whole":"92,260","shares_owned_after":129424.0,"shares_owned_after_display":"129,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-08","scope":"insider"},{"id":5955294,"accession":"0001179110-18-008316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-008316","line_url":"/filing/0001179110-18-008316#line-1","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10140.0,"shares_display":"10,140","price_per_share":24.0895,"price_display":"24.09","price_state":"stated","total_value":244267.53,"total_display":"244,267.53","total_whole":"244,268","shares_owned_after":133324.0,"shares_owned_after_display":"133,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-06","filed_date":"2018-06-08","scope":"insider"},{"id":4145288,"accession":"0001179110-17-012159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-012159","line_url":"/filing/0001179110-17-012159#line-1","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14670.0,"shares_display":"14,670","price_per_share":30.7669,"price_display":"30.77","price_state":"stated","total_value":451350.423,"total_display":"451,350.42","total_whole":"451,350","shares_owned_after":134327.0,"shares_owned_after_display":"134,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4308409,"accession":"0001179110-17-004176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-004176","line_url":"/filing/0001179110-17-004176#line-1","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26829.0,"shares_display":"26,829","price_per_share":31.86,"price_display":"31.86","price_state":"stated","total_value":854771.94,"total_display":"854,771.94","total_whole":"854,772","shares_owned_after":161453.0,"shares_owned_after_display":"161,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-07","scope":"insider"},{"id":2582345,"accession":"0001179110-16-028912","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-16-028912","line_url":"/filing/0001179110-16-028912#line-4","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37078.0,"shares_display":"37,078","price_per_share":27.16,"price_display":"27.16","price_state":"stated","total_value":1007038.48,"total_display":"1,007,038.48","total_whole":"1,007,038","shares_owned_after":195730.0,"shares_owned_after_display":"195,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-22","filed_date":"2016-08-22","scope":"insider"},{"id":2582336,"accession":"0001179110-16-028912","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-16-028912","line_url":"/filing/0001179110-16-028912#line-2","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4870.0,"shares_display":"4,870","price_per_share":28.14,"price_display":"28.14","price_state":"stated","total_value":137041.8,"total_display":"137,041.80","total_whole":"137,042","shares_owned_after":236816.0,"shares_owned_after_display":"236,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-22","scope":"insider"},{"id":2582330,"accession":"0001179110-16-028912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-028912","line_url":"/filing/0001179110-16-028912#line-1","is_derivative":false,"issuer_cik":"0001302448","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302448","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (EVP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel, Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7174.0,"shares_display":"7,174","price_per_share":28.55,"price_display":"28.55","price_state":"stated","total_value":204817.7,"total_display":"204,817.70","total_whole":"204,818","shares_owned_after":241686.0,"shares_owned_after_display":"241,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-18","filed_date":"2016-08-22","scope":"insider"},{"id":6779231,"accession":"0001179110-14-012846","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-012846","line_url":"/filing/0001179110-14-012846#line-3","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1048.0,"shares_display":"1,048","price_per_share":22.3,"price_display":"22.30","price_state":"stated","total_value":23370.4,"total_display":"23,370.40","total_whole":"23,370","shares_owned_after":446274.0,"shares_owned_after_display":"446,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-13","scope":"insider"},{"id":6779225,"accession":"0001179110-14-012846","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-012846","line_url":"/filing/0001179110-14-012846#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27108.0,"shares_display":"27,108","price_per_share":22.12,"price_display":"22.12","price_state":"stated","total_value":599628.96,"total_display":"599,628.96","total_whole":"599,629","shares_owned_after":447322.0,"shares_owned_after_display":"447,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-11","filed_date":"2014-08-13","scope":"insider"},{"id":6547420,"accession":"0001179110-14-004581","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-004581","line_url":"/filing/0001179110-14-004581","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65806.0,"shares_display":"65,806","price_per_share":36.73395009573595,"price_display":"36.73","price_state":"stated","total_value":2417314.32,"total_display":"2,417,314.32","total_whole":"2,417,314","shares_owned_after":328531.0,"shares_owned_after_display":"328,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-05","scope":"insider","n_lines":2},{"id":5386470,"accession":"0001179110-13-010143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-010143","line_url":"/filing/0001179110-13-010143#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31038.0,"shares_display":"31,038","price_per_share":35.04,"price_display":"35.04","price_state":"stated","total_value":1087571.52,"total_display":"1,087,571.52","total_whole":"1,087,572","shares_owned_after":303416.0,"shares_owned_after_display":"303,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-07","filed_date":"2013-06-11","scope":"insider"},{"id":9170163,"accession":"0001179110-11-015802","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-015802","line_url":"/filing/0001179110-11-015802#line-3","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":420000.0,"total_display":"420,000.00","total_whole":"420,000","shares_owned_after":350673.0,"shares_owned_after_display":"350,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-28","filed_date":"2011-11-30","scope":"insider"},{"id":9043169,"accession":"0001179110-11-004975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-004975","line_url":"/filing/0001179110-11-004975","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26689.0,"shares_display":"26,689","price_per_share":22.757582899321818,"price_display":"22.76","price_state":"stated","total_value":607377.13,"total_display":"607,377.13","total_whole":"607,377","shares_owned_after":346825.0,"shares_owned_after_display":"346,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-11","filed_date":"2011-03-15","scope":"insider","n_lines":2},{"id":3448348,"accession":"0001179110-08-014467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-014467","line_url":"/filing/0001179110-08-014467#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34676.0,"shares_display":"34,676","price_per_share":15.9675,"price_display":"15.97","price_state":"stated","total_value":553689.03,"total_display":"553,689.03","total_whole":"553,689","shares_owned_after":193268.0,"shares_owned_after_display":"193,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-08-01","scope":"insider"},{"id":7252822,"accession":"0001179110-07-020827","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-07-020827","line_url":"/filing/0001179110-07-020827#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":625000.0,"total_display":"625,000.00","total_whole":"625,000","shares_owned_after":222568.0,"shares_owned_after_display":"222,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7825411,"accession":"0001179110-07-015994","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-07-015994","line_url":"/filing/0001179110-07-015994","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":25.650666666666666,"price_display":"25.65","price_state":"stated","total_value":38476.0,"total_display":"38,476.00","total_whole":"38,476","shares_owned_after":247235.0,"shares_owned_after_display":"247,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider","n_lines":8},{"id":7775596,"accession":"0001179110-07-015992","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-26","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":41600.0,"total_display":"41,600.00","total_whole":"41,600","shares_owned_after":264435.0,"shares_owned_after_display":"264,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775594,"accession":"0001179110-07-015992","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-25","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":26.01,"price_display":"26.01","price_state":"stated","total_value":26010.0,"total_display":"26,010.00","total_whole":"26,010","shares_owned_after":266035.0,"shares_owned_after_display":"266,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775592,"accession":"0001179110-07-015992","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-24","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":26.02,"price_display":"26.02","price_state":"stated","total_value":15612.0,"total_display":"15,612.00","total_whole":"15,612","shares_owned_after":267035.0,"shares_owned_after_display":"267,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775588,"accession":"0001179110-07-015992","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-23","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":26.46,"price_display":"26.46","price_state":"stated","total_value":13230.0,"total_display":"13,230.00","total_whole":"13,230","shares_owned_after":269335.0,"shares_owned_after_display":"269,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775587,"accession":"0001179110-07-015992","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-22","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":26.67,"price_display":"26.67","price_state":"stated","total_value":10668.0,"total_display":"10,668.00","total_whole":"10,668","shares_owned_after":271335.0,"shares_owned_after_display":"271,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775585,"accession":"0001179110-07-015992","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-21","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":26.3,"price_display":"26.30","price_state":"stated","total_value":10520.0,"total_display":"10,520.00","total_whole":"10,520","shares_owned_after":268435.0,"shares_owned_after_display":"268,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775583,"accession":"0001179110-07-015992","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-20","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":26.29,"price_display":"26.29","price_state":"stated","total_value":7887.0,"total_display":"7,887.00","total_whole":"7,887","shares_owned_after":268135.0,"shares_owned_after_display":"268,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775581,"accession":"0001179110-07-015992","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-19","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":26.66,"price_display":"26.66","price_state":"stated","total_value":5332.0,"total_display":"5,332.00","total_whole":"5,332","shares_owned_after":271135.0,"shares_owned_after_display":"271,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775579,"accession":"0001179110-07-015992","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-18","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":26.55,"price_display":"26.55","price_state":"stated","total_value":5310.0,"total_display":"5,310.00","total_whole":"5,310","shares_owned_after":270435.0,"shares_owned_after_display":"270,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775577,"accession":"0001179110-07-015992","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-17","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":26.54,"price_display":"26.54","price_state":"stated","total_value":5308.0,"total_display":"5,308.00","total_whole":"5,308","shares_owned_after":270235.0,"shares_owned_after_display":"270,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775575,"accession":"0001179110-07-015992","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-16","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":26.48,"price_display":"26.48","price_state":"stated","total_value":5296.0,"total_display":"5,296.00","total_whole":"5,296","shares_owned_after":269835.0,"shares_owned_after_display":"269,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775573,"accession":"0001179110-07-015992","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-15","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":26.38,"price_display":"26.38","price_state":"stated","total_value":5276.0,"total_display":"5,276.00","total_whole":"5,276","shares_owned_after":269035.0,"shares_owned_after_display":"269,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775570,"accession":"0001179110-07-015992","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-14","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":26.24,"price_display":"26.24","price_state":"stated","total_value":5248.0,"total_display":"5,248.00","total_whole":"5,248","shares_owned_after":267735.0,"shares_owned_after_display":"267,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775568,"accession":"0001179110-07-015992","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-13","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":26.64,"price_display":"26.64","price_state":"stated","total_value":2664.0,"total_display":"2,664.00","total_whole":"2,664","shares_owned_after":271035.0,"shares_owned_after_display":"271,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775567,"accession":"0001179110-07-015992","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-12","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":26.63,"price_display":"26.63","price_state":"stated","total_value":2663.0,"total_display":"2,663.00","total_whole":"2,663","shares_owned_after":270935.0,"shares_owned_after_display":"270,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775565,"accession":"0001179110-07-015992","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-11","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":26.62,"price_display":"26.62","price_state":"stated","total_value":2662.0,"total_display":"2,662.00","total_whole":"2,662","shares_owned_after":270835.0,"shares_owned_after_display":"270,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775563,"accession":"0001179110-07-015992","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-10","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":26.6,"price_display":"26.60","price_state":"stated","total_value":2660.0,"total_display":"2,660.00","total_whole":"2,660","shares_owned_after":270735.0,"shares_owned_after_display":"270,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775560,"accession":"0001179110-07-015992","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-9","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":26.59,"price_display":"26.59","price_state":"stated","total_value":2659.0,"total_display":"2,659.00","total_whole":"2,659","shares_owned_after":270635.0,"shares_owned_after_display":"270,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775558,"accession":"0001179110-07-015992","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-8","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":26.52,"price_display":"26.52","price_state":"stated","total_value":2652.0,"total_display":"2,652.00","total_whole":"2,652","shares_owned_after":270135.0,"shares_owned_after_display":"270,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775556,"accession":"0001179110-07-015992","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-7","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":26.49,"price_display":"26.49","price_state":"stated","total_value":2649.0,"total_display":"2,649.00","total_whole":"2,649","shares_owned_after":270035.0,"shares_owned_after_display":"270,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7775554,"accession":"0001179110-07-015992","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-07-015992","line_url":"/filing/0001179110-07-015992#line-6","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302448","owner_name":"Shafer Bradford J","owner_display_name":"Shafer Bradford J","owner_url":"/insider/0001302448","role":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark":"O","role_mark_label":"Officer (Sr VP, Gen. Counsel, Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Gen. Counsel, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":26.44,"price_display":"26.44","price_state":"stated","total_value":2644.0,"total_display":"2,644.00","total_whole":"2,644","shares_owned_after":269235.0,"shares_owned_after_display":"269,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"}],"collapsed":true,"next_cursor":"2007-08-01|7775554","ledger_fault":false,"count":{"value":85,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":81,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":85},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001583107","name":"Theravance Biopharma, Inc.","url":"/issuer/0001583107","role":"Officer (EVP, Gen. Counsel, Secretary)","n_filings":6,"first_seen":"2016-08-22","last_seen":"2018-08-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001080014","name":"THERAVANCE INC","url":"/issuer/0001080014","role":"Officer (Sr VP, Gen. Counsel, Secretary)","n_filings":11,"first_seen":"2004-10-07","last_seen":"2014-08-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001302448","retrieved_at":"2026-08-23T23:19:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}